Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection.
OBJECTIVE
This study was conducted to compare viral dynamics in blood and semen between subjects with antibody negative, acute HIV-1 infection and other subjects with later stages of infection.


METHODS
A prospective cohort study was embedded within a cross-sectional study of HIV screening in a Lilongwe, Malawi STD clinic.


METHODS
Blood samples from HIV antibody negative or indeterminate volunteers were used to detect HIV RNA in plasma using a pooling strategy. Blood and seminal plasma HIV-1 RNA concentrations were measured over 16 weeks.


RESULTS
Sixteen men with acute HIV infection and 25 men with chronic HIV infection were studied. Blood viral load in subjects with acute HIV infection was highest about 17 days after infection (mean +/- SE, 6.9 +/- 0.5 log10 copies/ml), while semen viral load peaked about 30 days after infection (4.5 +/- 0.4 log10 copies/ml). Semen viral load declined by 1.7 log10 to a nadir by week 10 of HIV infection. Semen and blood viral loads were more stable in chronically infected subjects over 16 weeks. Higher semen levels of HIV RNA were noted in subjects with low CD4 cell counts.


CONCLUSIONS
These results provide a biological explanation for reported increases in HIV transmission during the very early (acute) and late stages of infection. Recognizing temporal differences in HIV shedding in the genital tract is important in the development of effective HIV prevention strategies.
Pilcher
Christopher D
CD
Center for Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7030, USA.
Joaki
George
G
Hoffman
Irving F
IF
Martinson
Francis E A
FE
Mapanje
Clement
C
Stewart
Paul W
PW
Powers
Kimberly A
KA
Galvin
Shannon
S
Chilongozi
David
D
Gama
Syze
S
Price
Matthew A
MA
Fiscus
Susan A
SA
Cohen
Myron S
MS
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002908:Chronic Disease; D018450:Disease Progression; D004812:Epidemiologic Methods; D015658:HIV Infections / Q000635:transmission / Q000821:virology*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis / Q000097:blood; D012661:Semen / Q000821:virology*; D019562:Viral Load; D014766:Viremia / Q000821:virology; D017201:Virus Shedding
D012367:RNA, Viral
N Engl J Med. 2000 Mar 30;342(13):921-9
10738050
J Infect Dis. 2007 Feb 1;195(3):416-24
17205481
AIDS. 2000 Dec 1;14(17):2751-7
11125894
J Infect Dis. 2001 Apr 1;183(7):1023-30
11237826
AIDS. 2001 May 4;15(7):837-45
11399956
AIDS Res Hum Retroviruses. 2001 Jul 1;17(10):901-10
11461676
JAMA. 2002 Jul 10;288(2):216-21
12095386
Nat Rev Microbiol. 2004 Jan;2(1):33-42
15035007
J Clin Invest. 2004 Apr;113(7):937-45
15057296
AIDS. 2004 Feb 20;18(3):517-24
15090805
J Infect Dis. 2004 May 15;189(10):1785-92
15122514
N Engl J Med. 1997 Apr 10;336(15):1072-8
9091805
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Mar 1;14(3):249-58
9117458
Lancet. 1997 Jun 28;349(9069):1868-73
9217758
JAMA. 1997 Dec 17;278(23):2085-9
9403423
J Infect Dis. 1998 Feb;177(2):320-30
9466517
J Infect Dis. 1998 Jun;177(6):1742-6
9607862
Sex Transm Infect. 1999 Feb;75(1):3-17
10448335
J Infect Dis. 2005 May 1;191(9):1391-3
15809893
J Infect Dis. 2005 May 1;191(9):1403-9
15809897
N Engl J Med. 2005 May 5;352(18):1873-83
15872202
Stat Med. 2006 Feb 15;25(3):513-27
16158407
J Theor Biol. 2000 Apr 7;203(3):285-301
10716909